The aim of this study was to evaluate the risk factors of peripheral arterial disease (PAD) and the relationship between ankle brachial index (ABI) and mortality from all-cause and cardiovascular disease (CVD) in Chinese patients with hypertension. The ABI cohort Study was designed to investigate risk factors of PAD and the relationship between ABI and mortality from all-cause and CVD in Chinese patients. ABI was identified at baseline by measuring systolic pressure at bilateral brachial and tibial arteries. Mortality surveillance was completed from November 2005 to January 2006. Among 3047 participants with hypertension at baseline, 839 (27.5%) were in the low-ABI group. Older age, female gender, higher serum level of triglycerides, lower serum level of high-density lipoprotein, a history of diabetes and a history of smoking were associated with low ABI. During the 13-month follow-up, there were 252 deaths, of which 100 died of CVD. Low ABI was associated with mortality from all-cause and CVD, whose adjusted relative risk was 1.619 (95% confidence interval 1.190-2.203) and 2.454 (1.531-3.933), respectively, in Cox regression models. The survival rate was significantly lower in the low-ABI group than in the normal-ABI group. This study demonstrated that low ABI was independently associated with a high risk of all-cause and CVD mortality in Chinese patients with hypertension. ABI should be promoted as an ideal tool to predict mortality in diabetic patients.
Introduction
Peripheral arterial disease (PAD) is a clinical manifestation of the atherosclerotic process, which is associated with the prevalence of cardiovascular disease (CVD) and increased CVD risk. 1, 2 Up to 20% of elderly individuals have PAD upon noninvasive testing. [3] [4] [5] [6] As only a small percentage of these individuals are symptomatic, PAD is poorly recognized in primary care practice. 7, 8 Several cohort studies have shown that a low ankle-brachial index (ABI) is a risk factor of fatal and nonfatal coronary heart disease and all-cause mortality among people with and without existing clinical coronary artery disease, and among people with existing peripheral vascular disease. [9] [10] [11] Low ABI is also associated with the incidence of stroke in the elderly. 2 Hypertension is a major chronic disease, which accelerates atherosclerosis. Numerous studies have identified hypertension as a key risk factor for PAD. 12 Several cohort and randomly selected studies have revealed that hypertension increase the risk of CVD and mortality in male physicians. 12 Except for one study that reported 16.7% PAD prevalence in Chinese patients with hypertension, this issue has not been researched extensively. 13 Thus, the purpose of this study was to evaluate the risk factors of PAD and to elucidate the relationship between ABI and mortality from all-cause and CVD in Chinese patients with hypertension.
Materials and methods

Study subjects
The ABI Cohort Study was designed in 2004 to investigate the risk factors of PAD and the relationship between ABI and mortality from all-cause and CVD. Subjects were recruited from the Endocrinology or Cardiology in-patient clinic at eight university hospitals in Beijing and Shanghai from July to November 2004. The diagnostic criterion came from 'Chinese Hypertension Guidelines', and the diagnosis of hypertension made with a single measurement of raised blood pressure. Participants were diagnosed with hypertension if they had a systolic blood pressure (SBP) X140 mm Hg and/or diastolic blood pressure (DBP) X90 mm Hg, or had a hypertension history according to medical reports at the baseline examination. Finally, 3047 participants, including 1601 men and 1446 women, entered our cohort study. The mean age of patients was 68.17710.60 years and they were followed up from November 2005 to January 2006. This study was approved by the ethics committee of Tongji University and informed consent was obtained from the participants.
Measurement of ankle and arm blood pressures
Doppler ultrasound (Nicolet Vascular, Elite 100R, USA) was used to measure systolic pressure at bilateral brachial, positional tibial and dorsal pedal arteries in the supine position after 5-min rest The occluding cuffs (55 Â 12.5 cm) were applied just above the malleoli to measure ankle pressure. The Doppler probe was used at a frequency of 5 MHz. Right and left ABI were calculated by the highest pressure at the dorsal or posterior tibial arteries on the corresponding sides, respectively, and by the highest brachial pressure on either side.
Diagnosis of PAD
Early studies used an ABI cutoff point, ranging from o0.95 to o0.80, to define PAD. 14, 15 Recently most studies have tended to use a cutoff point of o0.90. 16, 17 Carter considered that an ABI of o0.90 had 95% sensitivity and 99% specificity for angiographically documented PAD. 18 This cutoff point has also been accepted by the Strong Heart Study (SHS) where the upper limit of normal ABI should not exceed 1.40. 19 More recently, the American College of Cardiology and the American Heart Association (ACC/AHA) guidelines have recommended ABI p0.90 as the criterion for the diagnosis of PAD. 20 Thus, our study adopted this recommendation for participants with an ABI p0.90 in either leg as low ABI. These participants were diagnosed with PAD. On the other hand, participants with an ABI from 0.91 to 1.40 were considered normal.
Risk factors
A questionnaire was designed to collect information about general characteristics, diagnosis, medical history and relation factors, medical treatment and biochemical examination. More specifically, possible risk factors in this questionnaire included age, sex, body mass index (BMI), history of diabetes, hyperlipidaemia and smoking. As for the biochemical index, total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), lowdensity lipoprotein cholesterol (LDL-C) and fasting plasma glucose (FPG) were measured.
Identification of all-cause and CVD mortality Deaths were confirmed from hospital records or by contact with participants and their families. Cause of death was investigated using medical records from the state health department as the basis of interviews. All materials were reviewed independently by a physician of the ABI cohort Study to confirm the cause of death.
Statistical analysis
Data were analysed using the software program SPSS13.0. Continuous variables were expressed as the mean 7s.d., and categorical variables as a percentage. Independent-samples t-test and the w 2 test were used to compare continuous and categorical differences, respectively. A P-value o0.05 was considered statistically significant. Crude deaths from all-cause and CVD were examined by ABI stratification. The relationships between ABI and deaths from all-cause and CVD were adjusted for potential confounders, including age, gender, diabetes, hyperlipidemia and smoking experience, using the Cox regression model.
Results
There were 3047 participants with hypertension whose baseline ABI was available. Of these, 839 participants (27.5%) were in the low-ABI group and the remainder was in the normal-ABI group. According to our criteria described above, the prevalence of PAD was 27.5% in this study. During 13-month follow-up, there were 252 deaths, and 100 died of CVD.
Comparison of baseline characteristics in two ABI groups As shown in Table 1 , participants with low ABI were older and had a lower BMI, higher SBP, higher TC, higher FPG, fewer of male gender, more diabetes and had a history of smoking in comparison with those with normal ABI at baseline.
Independent risk factors for low ABI
Logistic regression analysis was used to evaluate the independent significance of associated factors. Table 1 shows the adjusted odds ratios (ORs) and 95% confidence interval (CI) for low-ABI participants. We found that older age, female gender, higher level of SBP, higher serum level of TC, lower serum level of HDL and having a history of diabetes or smoking were associated with low ABI in patients with hypertension.
All-cause and CVD mortality in low and normal ABI groups All-cause mortalities in low-and normal-ABI groups were 13.8 and 6.2%, respectively. On the other hand, CVD mortalities were 6.1 and 2.2%, respectively. All-cause and CVD mortality was significantly higher in the low-ABI group than in the normal-ABI group. The crude OR of the low-ABI group was 2.444 (95% CI 1.881-3.176) for all-cause mortality, and 2.852 (95% CI 1.911-4.256) for CVD mortality. When low-and normal-ABI groups were examined in relation to mortality using Cox regression models adjusted for multiple CVD risk factors, low ABI was associated with an adjusted all-cause and CVD mortality risk of 1.619 (95% CI 1.190-2.203) and 2.454 (1.531-3.933), respectively. Figure 1a and b show the survival distribution of the two ABI groups for all-cause and CVD mortality, respectively. The survival rate for the low-ABI group was significantly lower than that for the normal-ABI group for both all-cause and CVD mortality (Po0.001).
Survival analysis for low-and normal-ABI groups
All-cause and CVD mortality in different ABI groups If ABI was subdivided into p0.4, 0.41-0.90, 0.91-0.99 and 1.00-1.40, all-cause mortality was 24.7, 12.7, 6.9, 6.0, respectively (Po0.001) (Figure 2 ). CVD mortality was 14.3, 5.2, 2.9, 2.1, with significant differences from each other (Po0.001). Low ankle brachial index and mortality in hypertension patients YY Luo et al Figure 3a and b show the adjusted relative risk (RR) of different ABI groups. The ABI groups were examined in relation to mortality in Cox regression models adjusted for age, sex, history of diabetes and smoking. The mortality risk from all-cause and CVD elevated with decreased ABI.
Mortality risks according to different ABI groups
Discussion
A previous study demonstrated that PAD prevalence in Chinese diabetic patients was 16.7%, and the major independent risk factors were age, sex, BMI, history of HBP and smoking. 13 In this study, PAD prevalence was 27.5% in hypertension patients, which was much higher than that in diabetic patients. It is possible that patients with hypertension had a higher risk for PAD than patients with type II diabetes. It is also possible that different sample sizes and different criteria for diagnosis resulted in variations in the reported overall prevalence.
Low-ABI patients were older by univariate analysis and the adjusted OR was 1.070 (95% CI 1.058-1.082) by logistic regression analysis. Consistent with the previous study, female gender was shown as a risk factor for low ABI. 13 This study showed that patients with low ABI had a lower BMI; however, BMI was not an independent risk for low ABI after logistic regression analysis. In our study, patients with low ABI were also associated with higher SBP, and DBP was not significantly different between low ABI and normal ABI by univariate analysis. Higher SBP level was an independent risk for low ABI after logistic regression analysis. A history of diabetes and smoking was an independent risk for low ABI with an adjusted OR of 1.861 (1.495-2.318) and 1.788 (1.396-2.290), respectively; therefore, antidiabetes medications and cessation of smoking are very important for Chinese patients with hypertension. Patients with low ABI had a higher serum level of TC; however, TG, HDL-C and LDL-C were not significantly different between low ABI and normal ABI, and a higher serum level of TC and lower serum level of HDL were independent risks for low ABI with adjusted OR of 1.217 (95% CI 1.044-1.418) and 0.716 (95% CI 0.535-0.958). It is therefore very important to improve lipidaemia when treating hypertensive patients in China.
All-cause and CVD mortalities were 13.8 and 6.1% in the low-ABI group, twice as high as those with normal ABI. Compared with the normal-ABI group, the adjusted RR after 13-month follow-up was 1.619 (95% CI 1.190-2.203) for all-cause death and 2.454 (95% CI 1.531-3.933) for CVD death in Chinese hypertensive patients. This is comparable with previous reports that individuals with low ABI are at increased risk of death relative to individuals with normal ABI. 21, 22 Our results are strikingly similar to the SHS study, in which RRs of all-cause and CVD mortality after 10-year follow-up were 1.69 and 2.52, respectively. 17 In the Edinburgh artery study, RRs of all-cause and CVD mortality after 5-year follow-up were 1.58 and 1.85, respectively, for persons aged 55-74 years old with ABI o0.90.
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CVD mortality is higher in our study than in the Edinburgh artery study. It is possible that hypertensive patients with low ABI are more susceptible to CVD death. Other possibilities include different ethnic groups and different duration of follow-up; however, an ABI of p0.90 was independently associated with a high risk of all-cause and CVD mortality.
When participants were furthermore divided into four ABI groups, all-cause and CVD mortality still differed among the groups. The lowest ABI (p0.4) group had the highest all-cause and CVD mortality. Mortality declined with ABI elevation. In comparison with the highest ABI (1.00-1.40) group, the adjusted RR of all-cause and CVD mortality was elevated at the lower end of ABI distribution. The adjusted risks of all-cause mortality in the p0.4 group and 0.41-0.90 group were 3.5 and 1.4 times that of the 1.00-1.40 group. The adjusted risks of CVD mortality in the p0.4 group and 0.41-0.90 group were 6.6 and 2.2 times that of the 1.00-1.40 group. This demonstrated that low ABI was independently associated with an increased risk of allcause and CVD mortality in Chinese hypertensive patients. In other words, a patient has a higher risk of all-cause and CVD mortality with a lower ABI. The adjusted risk of all-cause and CVD mortality for the 0.91-0.99 group, defined as the equivocal ABI level by PAD guidelines, 19 was not significantly different from the 1.00-1.40 group in this study.
In conclusion, our study analysed the risk factors of PAD and the relationship between low ABI and all-cause and CVD mortality in Chinese patients with hypertension. Older age, female gender, higher serum level of TC, lower serum level of HDL, a history of diabetes and smoking were independent risk factors for low ABI. After 13-month follow-up, low ABI was independently associated with an increased risk of all-cause and CVD mortality. Survival functions were significantly lower in the low-ABI group than in the normal-ABI group. Our findings further supported that ABI should be promoted as an ideal tool to predict mortality in hypertensive patients. Regular PAD screening in hypertension and then intensive management of vascular risk factors should be encouraged in clinical practice.
